Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biostem Technologies Inc (BSEM)

Biostem Technologies Inc (BSEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 289,337
  • Shares Outstanding, K 16,619
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta -0.36
  • Price/Sales 23.26
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 34.35
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.32 on 11/12/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.5700 +64.71%
on 10/21/24
28.2565 -38.39%
on 11/12/24
+5.4100 (+45.08%)
since 10/14/24
3-Month
9.4000 +85.21%
on 09/11/24
28.2565 -38.39%
on 11/12/24
+4.7900 (+37.96%)
since 08/14/24
52-Week
2.3420 +643.38%
on 11/20/23
28.2565 -38.39%
on 11/12/24
+14.1700 (+437.35%)
since 11/14/23

Most Recent Stories

More News
Small and Micro-Cap Movers: Your Daily Digest of High-Impact News From High-Growth Companies Rising in Popularity

WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our focus is on quality, liquid, growth-oriented companies in...

BCHT : 0.6985 (-1.62%)
MNTS : 0.6251 (-5.72%)
ONTF : 6.46 (-2.86%)
RELL : 14.16 (+1.22%)
BSEM : 17.4100 (-25.45%)
MOGO : 1.3300 (-5.67%)
TRAK : 20.86 (-2.71%)
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million

BSEM : 17.4100 (-25.45%)
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions

BSEM : 17.4100 (-25.45%)
BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

BSEM : 17.4100 (-25.45%)
BioStem Technologies to Present at the LD Micro Main Event XVII on Wednesday, October 30, 2024, at 9:30 AM PT

Presentation to be webcast, with management participating in 1-on-1 meetings at the Luxe Sunset Boulevard Hotel in Los AngelesPompano Beach, Florida--(Newsfile Corp. - October 23, 2024) - BioStem Technologies,...

BSEM : 17.4100 (-25.45%)
BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment

BSEM : 17.4100 (-25.45%)
BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions

BSEM : 17.4100 (-25.45%)
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments

Miami, Florida--(Newsfile Corp. - July 16, 2024) - Innovation is the lifeblood of the MedTech sector. Literally. Discoveries made are more than value drivers for the companies behind them; they can be...

BSEM : 17.4100 (-25.45%)
BioStem Technologies® CEO to Appear on the Benzinga All Access Show on June 17,2022

POMPANO BEACH, FLORIDA, June 17, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading, innovator focused on harnessing the natural...

OTC.VN : 0.330 (unch)
BSEM : 17.4100 (-25.45%)
BioStem Technologies Reports March 31, 2022 Record Quarterly Financial Results

POMPANO BEACH, FLORIDA., May 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the...

OTC.VN : 0.330 (unch)
BSEM : 17.4100 (-25.45%)

Business Summary

BioStem Technologies Inc. is a regenerative medicine company. It focused on the development, manufacture and commercialization of placental derived biologics. The company's portfolio of brands includes VENDAJE(R), VENDAJE AC(R) and VENDAJE OPTIC(R). BioStem Technologies Inc. is based in POMPANO BEACH,...

See More

Key Turning Points

3rd Resistance Point 28.3433
2nd Resistance Point 25.7967
1st Resistance Point 21.6033
Last Price 17.4100
1st Support Level 14.8633
2nd Support Level 12.3167
3rd Support Level 8.1233

See More

52-Week High 28.2565
Fibonacci 61.8% 18.3572
Last Price 17.4100
Fibonacci 50% 15.2992
Fibonacci 38.2% 12.2413
52-Week Low 2.3420

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar